2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Head And Neck Cancers
In the realm of cancer research, head and neck cancers present a complex challenge due to their diverse origins and intricate anatomical structures. These malignancies encompass tumors in the oral cavity, throat, larynx, and adjacent regions. Recent advancements in understanding the molecular mechanisms driving these cancers have spurred innovative therapeutic approaches. Targeted therapies and immunotherapies are emerging as promising avenues, aiming to combat specific genetic mutations and harness the body's immune system to fight cancer cells. Additionally, precision medicine techniques enable tailored treatment strategies, optimizing outcomes while minimizing side effects. Furthermore, multidisciplinary collaborations among oncologists, surgeons, geneticists, and researchers are fostering comprehensive care paradigms for patients. Through relentless exploration and collaboration, the landscape of head and neck cancer research continues to evolve, offering hope for improved diagnostics, treatments, and ultimately, patient survival and quality of life.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China